[{"data":1,"prerenderedAt":48},["ShallowReactive",2],{"q-nurse-113-2-basic-medicine-040":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":24},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":23},"nurse-113-2-基礎醫學-040","nurse-113-2-basic-medicine-040",113,2,40,"有關克隆氏症（Crohn’s disease）之治療，下列那一個藥物屬於 TNF-α 抑制劑？",{"A":15,"B":16,"C":17,"D":18},"adalimumab","vedolizumab","ustekinumab","tofacitinib","A",null,[],"本題考點在於克隆氏症生物製劑的作用標的分類。依免疫藥理，adalimumab 為抗腫瘤壞死因子 α（TNF-α）的單株抗體，中和促發炎的 TNF-α 以控制克隆氏症的腸道發炎，故選 A。B vedolizumab 作用於 α4β7 整合素阻斷淋巴球歸巢。C ustekinumab 針對 IL-12\u002FIL-23 的 p40 次單元。D tofacitinib 為 JAK 激酶抑制劑，三者標的皆非 TNF-α。",1,[25,29,32,36,40,44],{"webId":26,"stem":27,"number":23,"year":28,"session":23},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",106,{"webId":30,"stem":31,"number":11,"year":28,"session":23},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",{"webId":33,"stem":34,"number":35,"year":28,"session":23},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",3,{"webId":37,"stem":38,"number":39,"year":28,"session":23},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":41,"stem":42,"number":43,"year":28,"session":23},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":45,"stem":46,"number":47,"year":28,"session":23},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840771307]